American Medical Association warns DOJ not to settle case against Anthem-Cigna deal


The American Medical Association is sounding the alarm about the possibility of “politically driven settlement negotiations” between Anthem and the Justice Department that would result in the insurer closing its deal with Cigna.

In a letter sent to Acting Assistant Attorney General Brent Snyder, AMA CEO James Madara, M.D., urged the DOJ and states that sued to block the Anthem-Cigna merger to reject any offers to settle the case.

A federal judge blocked the deal in early February, and Anthem has been granted an expedited appeal of that ruling. However, it is fighting a separate court battle with Cigna, which sued to end the merger agreement and collect damages. Anthem them countersued, and the Delaware Court of Chancery has since approved its motion to temporarily stop Cigna from exiting the contract.   


2019 Drug Pricing and Reimbursement Stakeholder Summit

Given federal and state pricing requirements arising, press releases from industry leading pharma companies, and the new Drug Transparency Act, it is important to stay ahead of news headlines and anticipated requirements in order to hit company profit targets, maintain value to patients and promote strong, multi-beneficial relationships with manufacturers, providers, payers, and all other stakeholders within the pricing landscape. This conference will provide a platform to encourage a dialogue among such stakeholders in the pricing and reimbursement space so that they can receive a current state of the union regarding regulatory changes while providing actionable insights in anticipation of the future.

It is Anthem’s response to Cigna’s suit that alarmed the AMA, as the insurer said that it is “committed to completing this value-creating merger either through a successful appeal or through settlement with the new leadership at the Department of Justice.”

In fact, one of the contenders to lead the DOJ’s antitrust division under the Trump administration is none other than Makan Delrahim, who previously lobbied Congress on antitrust issues on behalf of Anthem starting in July 2015, Bloomberg Law reported. Delrahim deregistered as a lobbyist for the insurer in December.

Madara’s letter also noted that an Anthem attorney said in open court that the company believes a “supportive” Vice President Mike Pence enhances the deal’s chances of closing.

“We strongly believe that political influence should play no role in the enforcement of the antitrust laws and urge you to vigorously defend Judge Jackson’s ruling,” Madara wrote to Snyder.

Blocking the proposed deal completely, he added, “is the only way to adequately protect patients and physicians from the anticompetitive effects of an Anthem-Cigna merger.”

Suggested Articles

Health insurers’ financial performance is on a continuing upward trend, but political and legal risks could pose a threat to that growth.

Senate lawmakers released a draft package of legislation Thursday aimed at curbing health care costs they said they believe they can pass on a bipartisan basis…

Attorneys general seeking to defend the ACA argue that their opponents—including the DOJ—have poor legal standing to challenge the law.